These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8081462)

  • 1. Determination of 9 alpha, 11 beta-prostaglandin F2 in human urine and plasma by gas chromatography-mass spectrometry.
    Obata T; Nagakura T; Kammuri M; Masaki T; Maekawa K; Yamashita K
    J Chromatogr B Biomed Appl; 1994 May; 655(2):173-8. PubMed ID: 8081462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethylisopropylsilyl ether derivatives in gas chromatography-mass spectrometry of some prostanoids. Application to the microdetermination of 15-ketoprostaglandin F2 alpha formed by enzymatic conversion of PGF2 alpha in vitro.
    Yamashita K; Watanabe K; Ishibashi M; Katori M; Miyazaki H
    J Chromatogr; 1988 Jan; 424(1):1-11. PubMed ID: 3163336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
    Schweer H; Watzer B; Seyberth HW; Nüsing RM
    J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of the primary prostanoids prostaglandin E2, prostaglandin F2 alpha and 6-oxoprostaglandin F1 alpha by immunoaffinity chromatography in combination with negative ion chemical ionization gas chromatography-tandem mass spectrometry.
    Mackert G; Reinke M; Schweer H; Seyberth HW
    J Chromatogr; 1989 Sep; 494():13-22. PubMed ID: 2685002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure.
    Nourooz-Zadeh J; Gopaul NK; Barrow S; Mallet AI; Anggård EE
    J Chromatogr B Biomed Appl; 1995 May; 667(2):199-208. PubMed ID: 7663692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GC/MS analysis of urinary excretion of 9alpha,11beta-PGF2 in acute and exercise-induced asthma in children.
    Nagakura T; Obata T; Shichijo K; Matsuda S; Sigimoto H; Yamashita K; Masaki T; Maekawa K
    Clin Exp Allergy; 1998 Feb; 28(2):181-6. PubMed ID: 9515591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass fragmentographic determination of prostaglandin F2 alpha in human and rabbit urine.
    Sjöquist B; Oliw E; Lundén I; Anggård E
    J Chromatogr; 1979 May; 163(1):1-9. PubMed ID: 575141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of prostaglandin D2 metabolites in urine: comparison between enzyme immunoassay and negative ion chemical ionisation gas chromatography-mass spectrometry.
    O'Sullivan S; Mueller MJ; Dahlén SE; Kumlin M
    Prostaglandins Other Lipid Mediat; 1999 May; 57(2-3):149-65. PubMed ID: 10410385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective clean-up method using an immunoaffinity column following radioimmunoassay of prostaglandin F2 alpha in biological fluids.
    Murai Y; Ohno M; Konishi M; Kominami G
    J Chromatogr; 1992 Apr; 597(1-2):201-5. PubMed ID: 1517318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of plasma prostaglandin F2 alpha using capillary gas chromatography negative ion chemical ionization mass spectrometry.
    Herold DA; Smith BJ; Ross RM; Redpath G; Arlinghaus A; Wills MR; Savory J
    Ann Clin Lab Sci; 1987; 17(5):300-5. PubMed ID: 3479038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas chromatography-mass spectrometry of some prostanoids with new derivatizing agents. Application to the analysis of 13,14-dihydro-15-ketoprostaglandin F2 alpha.
    Yamashita K; Watanabe K; Ishibashi M; Miyazaki H; Yokota K; Horie K; Yamamoto S
    J Chromatogr; 1987 Jul; 399():223-34. PubMed ID: 3654856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of prostaglandin E2, prostaglandin F2 alpha and 6-oxo-prostaglandin F1 alpha in urine by gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry: a comparison.
    Schweer H; Seyberth HW; Schubert R
    Biomed Environ Mass Spectrom; 1986 Nov; 13(11):611-9. PubMed ID: 2948587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
    O'Sullivan S; Dahlén B; Dahlén SE; Kumlin M
    J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans.
    Wendelborn DF; Seibert K; Roberts LJ
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):304-8. PubMed ID: 3422430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy.
    Walter MF; Blumberg JB; Dolnikowski GG; Handelman GJ
    Anal Biochem; 2000 Apr; 280(1):73-9. PubMed ID: 10805523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 9alpha, 11beta prostaglandin F2 in human urine. combination of solid-phase extraction and radioimmunoassay.
    Mucha ; Riutta A
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):271-80. PubMed ID: 11993720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
    Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F
    J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific and rapid quantification of 8-iso-prostaglandin F2alpha in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry.
    Tsikas D; Schwedhelm E; Fauler J; Gutzki FM; Mayatepek E; Frölich JC
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):7-17. PubMed ID: 9824213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans.
    Liston TE; Roberts LJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6030-4. PubMed ID: 3862115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.